Virtual Reality Attention Management for ADHD

This study is testing a new approach called Virtual Reality (VR) Treatment to help children with Attention-Deficit/Hyperactivity Disorder (ADHD) manage distractions. The VR Treatment uses virtual reality to help children learn to ignore things that might distract them, based on how our brains learn to get used to repeated sights or sounds (habituation). Researchers will compare this to a VR Active Control, which is a VR experience without these distractions. The study is looking for children aged 8 to 12 years old who have significant problems with inattention. Success in this study will be measured by whether children make fewer eye and head movements towards distractions after 5-7 weeks. The current status of this study is unclear.

Study design: This interventional study plans to enroll 50 participants. Participants will receive either VR Treatment (with distractors) or VR Active Control (without distractors).
What's involved: Not specified in the trial record.
Compensation: Not stated in the trial record.
Follow-up: The primary endpoints are measured at 5-7 weeks after the intervention begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Virtual Reality Attention Management

Recruiting

NAAges 8–12InterventionalTreatment

University of California, Davis

~50 participants

Updated 2026-08-07 on ClinicalTrials.gov

What's tested:VR TreatmentVR Active Control

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Decrease in the amount of eye movements toward the distractors and/or shorter duration of fixation on distractors.

Measured over 5-7 weeks

+1 more outcome measured

Conditions

ADHD

Where it's being run

1 sites across 1 states

California1

Study leadership

Julie Schweitzer, PhD · PRINCIPAL_INVESTIGATOR · UC Davis MIND Institute

Who to contact

Juan Ramos

[email protected]

916-703-0294

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

Significant (T score \>= 60) ratings of Cognitive Problems/Inattention or DSM Inattention scale scores on the Conners' Parent or Teacher Rating Scale-3 or Parent ADHD Rating Scale-IV (ADHD-RS)

Endorsement of 4 or more symptoms of inattention on a clinical psychiatric interview (e.g. Parent DISC, DICA, Kiddie-SADS, Mini-KID)

Comfortable using a computer

Full Scale IQ \> 80

Exclusion

Psychosis (by parent report at phone screen), significant depression, autism (15 or \> on Social Communication Questionnaire (SCQ)), psychotic disorders, visual or hearing impairment or any other disorder that may interfere with task performance

It is in the investigator's opinion that it is not in the subject's best interest to continue

Subject is non-compliant with training schedule

Subjects on pharmacotherapy for ADHD at the time of enrollment will be excluded from Aims 3 and 4.

Subjects starting behavioral or psychological treatment for ADHD during the training phase of the study will be excluded

What this trial measures

Decrease in the amount of eye movements toward the distractors and/or shorter duration of fixation on distractors.5-7 weeks
Successful distractor suppression = improvement in number of orienting eye saccades toward distractors and duration of fixations by a statistical effect size of 0.5 or greater.
Decrease in the amount of head movements toward the distractors5-7 weeks
Successful decrease in head movements = improvement in extent or duration of head movements by a statistical effect size of 0.5 or greater.

Trialytics